Live Breaking News & Updates on ஜான் தேரோ

Stay updated with breaking news from ஜான் தேரோ. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Amarin (AMRN) Q1 2021 Earnings Call Transcript


Amarin (AMRN) Q1 2021 Earnings Call Transcript
Motley Fool Transcribing
© The Motley Fool
Logo of jester cap with thought bubble.
Amarin (NASDAQ: AMRN)
Welcome to Amarin Corporation s conference call to discuss its first-quarter 2021 financial results and operational updates. This conference call is being recorded today, April 29, 2021. I would like to turn the conference call over to Alina Doubrovna, associate manager of investor relations at Amarin.
Alina Doubrovna
Associate Manager of Investor Relations
Thank you, operator, and thank you to everyone for joining our first-quarter 2021 results. Before we begin, let me turn to our forward-looking statements. Please be aware that this conference call will contain forward-looking statements that are intended to be covered under the safe harbor provided by the Private Securities Litigation Reform Act. Examples of such statements include, but are not limited to: our current exp ....

New York , United States , Hong Kong , United Kingdom , New Jersey , Europe Karim Mikhail , Jessica Fye , Aaron Berg , Mike Kalb , Michael Yee , Louise Chen Cantor Fitzgerald , Karim Mikhail , John Thero , Michael Kalb , Joe Kennedy , Alina Doubrovna , Steve Ketchum , Paul Choi Goldman Sachs , Piper Sandler , Louise Chen , Michael Yee Jefferies , Paul Choi , Yasmeen Rahimi , Yasmeen Rahimi Piper Sandler , Egyptian Cardiovascular Society , European Commission ,

Amarin Reports First Quarter 2021 Financial Results and Provides Business Update


Share:
Commercial Launch of VAZKEPA in Europe on Track to Commence in Q3 2021 Following Recent Market Authorization with VASCEPA® Growth in the United States Positioned to Increase as the Impact of COVID-19 Recedes
Expenses Managed in Q1 2021 to Minimize Operating Loss Despite Revenue Impact of COVID-19 and Other Factors
Management to Host Conference Call Today at 7:30 a.m. ET
DUBLIN, Ireland and BRIDGEWATER, N.J., April 29, 2021 (GLOBE NEWSWIRE) Amarin Corporation plc (NASDAQ:AMRN), today announced financial results for the quarter ended March 31, 2021 and provided an update on company operations.
Recent Key Amarin Highlights:
Q1 net total revenue
: Net total revenue in the first quarter of 2021 was $142.2 million, consisting of $140.8 million in net product revenue from the United States, $0.5 million in net product revenue from outside the United States and $0.8 million in licensing and royalty revenue. Net product revenue from the United State ....

United States , Hong Kong , New Jersey , United Kingdom , United Arab Emirates , Northern Ireland , Great Britain , Coll Cardiol , Clin Cardiol , Karim Mikhail , John Thero , Joseph Kennedy , American Heart Association , Exchange Commission Regulation , European Society Of Cardiology , Journal Of The American College Cardiology , Amarin Pharmaceuticals Ireland , European Union , Chinese National Medical Products Administration , Symphony Health , Drug Administration , European Commission , Exchange Commission , Hong Kong Department Of Health , Amarin Corporation , Chinese Society Of Cardiology ,

MHRA authorises Amarin's heart drug Vazkepa

MHRA authorises Amarin's heart drug Vazkepa
pharmatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmatimes.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , Great Britain , Amarin Vazkepa , John Thero , Regulatory Agency , ஒன்றுபட்டது கிஂக்டம் , நன்று பிரிட்டன் , ஜான் தேரோ ,